Journal Article

No Clinical Benefit of Empirical Antimicrobial Therapy for Pediatric Diarrhea in a High-Usage, High-Resistance Setting

Vi, Lu Lan, de Alwis, Ruklanthi, Phuc, Hoang Le, Campbell, James I, Van Minh, Pham, Nhi, Le Thi Quynh, Tu, Le Thi Phuong, Huong, Nguyen Thi Thanh, Nhu, Tran Do Hoang, Thompson, Corinne N, Tuyen, Ha Thanh, Ngoc, Nguyen Minh, Duong, Vu Thuy, Hung, Nguyen Thanh, Thwaites, Guy E, Chau, Tran Thi Hong, Baker, Stephen

2018

Overview

Pediatric diarrheal disease presents a major public health burden in low- to middle-income countries. The clinical benefits of empirical antimicrobial treatment for diarrhea are unclear in settings that lack reliable diagnostics and have high antimicrobial resistance (AMR). We conducted a prospective multicenter cross-sectional study of pediatric patients hospitalized with diarrhea containing blood and/or mucus in Ho Chi Minh City, Vietnam. Clinical parameters, including disease outcome and treatment, were measured. Shigella, nontyphoidal Salmonella (NTS), and Campylobacter were isolated from fecal samples, and their antimicrobial susceptibility profiles were determined. Statistical analyses, comprising log-rank tests and accelerated failure time models, were performed to assess the effect of antimicrobials on disease outcome. Among 3166 recruited participants (median age 10 months; interquartile range, 6.5-16.7 months), one-third (1096 of 3166) had bloody diarrhea, and 25% (793 of 3166) were culture positive for Shigella, NTS, or Campylobacter. More than 85% of patients (2697 of 3166) were treated with antimicrobials; fluoroquinolones were the most commonly administered antimicrobials. AMR was highly prevalent among the isolated bacteria, including resistance against fluoroquinolones and third-generation cephalosporins. Antimicrobial treatment and multidrug resistance status of the infecting pathogens were found to have no significant effect on outcome. Antimicrobial treatment was significantly associated with an increase in the duration of hospitalization with particular groups of diarrheal diseases. In a setting with high antimicrobial usage and high AMR, our results imply a lack of clinical benefit for treating diarrhea with antimicrobials; adequately powered randomized controlled trials are required to assess the role of antimicrobials for diarrhea.

• Publisher: Oxford University Press
• Subject: Accelerated tests / Adolescent / and Commentaries / Anti-Bacterial Agents - therapeutic use / Antiinfectives and antibacterials / Antimicrobial agents / Antimicrobial resistance / Bacteria / Campylobacter / Campylobacter - drug effects / Cephalosporins / Child / Child, Preschool / Clinical trials / Cross-Sectional Studies / Diarrhea / Diarrhea - drug therapy / Diarrhea - microbiology / Drug resistance / Drug Resistance, Multiple, Bacterial / Empirical analysis / Failure analysis / Feces - microbiology / Female / Fluoroquinolones / Humans / Infant / Male / Medical treatment / Microbial Sensitivity Tests / Mucus / Multidrug resistance / Patients / Pediatrics / Prevalence / Prospective Studies / Public health / Rank tests / Salmonella / Salmonella - drug effects / Shigella / Shigella - drug effects / Statistical analysis / Statistical methods / Treatment Outcome / Vietnam